Table 1.
Demographic and lesion data.
| FNA (n = 33) | FNB (n = 31) | Overall (n = 64) | |
|---|---|---|---|
| Age, year | |||
| Mean (SD) | 68.8 (9.89) | 69.3 (11.0) | 69.0 (10.4) |
| Median [min, max] | 68.0 [52.0, 88.0] | 74.0 [40.0, 89.0] | 68.5 [40.0, 89.0] |
| Gender, n (%) | |||
| Male | 20 (60.6) | 14 (45.2) | 34 (53.1) |
| Female | 13 (39.4) | 17 (54.8) | 30 (46.9) |
| Body mass index, kg/m2 | |||
| Mean (SD) | 24.6 (3.99) | 24.3 (4.00) | 24.4 (3.97) |
| Median [min, max] | 25.3 [17.7, 31.2] | 23.9 [15.8, 33.3] | 24.2 [15.8, 33.3] |
| ASA score, n (%) | |||
| I | 10 (30.3) | 8 (25.8) | 18 (28.1) |
| II | 15 (45.5) | 17 (54.8) | 32 (50.0) |
| III | 8 (24.2) | 6 (19.4) | 14 (21.9) |
| Location of the lesion, n (%) | |||
| Head | 15 (45.5) | 12 (38.7) | 27 (42.2) |
| Neck | 4 (12.1) | 2 (6.5) | 6 (9.4) |
| Body | 6 (18.2) | 9 (29.0) | 15 (23.4) |
| Tail | 3 (9.1) | 3 (9.7) | 6 (9.4) |
| Uncinate | 4 (12.1) | 5 (16.1) | 9 (14.1) |
| Diffuse involvement | 1 (3.0) | 0 (0) | 1 (1.6) |
| Size of the lesion, mm | |||
| Mean (SD) | 29.7 (13.1) | 29.5 (14.2) | 29.6 (13.5) |
| Median [min, max] | 30.0 [5.00, 60.0] | 30.0 [8.00, 72.0] | 30.0 [5.00, 72.0] |
| Final diagnosis, n (%) | |||
| Adenocarcinoma | 25 (75.8) | 20 (64.5) | 45 (70.3) |
| Neuroendocrine neoplasm | 3 (9.1) | 5 (16.1) | 8 (12.5) |
| Chronic pancreatitis | 1 (3.0) | 1 (3.2) | 2 (3.1) |
| Metastasis from other tumor | 1 (3.0) | 4 (12.9) | 5 (7.8) |
| Normal pancreatic tissue | 2 (6.1) | 1 (3.2) | 3 (4.7) |
| Adenoma | 1 (3.0) | 0 (0) | 1 (1.6) |
ASA, American Society of Anesthesiologists; FNA, fine-needle aspiration; FNB, fine-needle biopsy.